New buyers Mr. Kotha and Mr. Kumar are acquiring a 20.95% promoter stake in Dolphin Medical Services, triggering a 26% open offer to public shareholders at ₹4.80 per share.
Detailed Coverage
Dolphin Medical Services Ltd: Management Control Change and Open Offer Triggered
**Offer Price per Equity Share:** ₹4.80 **Shares proposed to be acquired in Open Offer:** 39,25,988 ## What just happened Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar have agreed to purchase a 20.95% stake in Dolphin Medical Services Ltd from the current promoters, Mr. Gude Venkata Mohan Prasad and Mrs. Lakshmi Sudha Madala. This deal has initiated a mandatory open offer for an additional 26% stake from the public shareholders. ## Why this matters The acquisition signals a change in management control for Dolphin Medical Services. The open offer at ₹4.80 per share presents an exit opportunity for public shareholders at a premium to the promoter acquisition price. The acquirers intend to continue the existing business operations. ## The backstory For the fiscal year ending March 31, 2026, Dolphin Medical Services reported a profit of ₹4.19 lakh. This marks a turnaround from net losses of ₹3.38 lakh in FY25 and ₹10.40 lakh in FY24. Revenue from operations stood at ₹75.01 lakh for FY26. ## What changes now A new controlling bloc is set to emerge, subject to the successful completion of the open offer. The acquirers plan to maintain the company's focus on healthcare and diagnostic services. ## Risks to watch Investors face several risks. Trading in Dolphin Medical Services shares is currently restricted to Mondays due to non-payment of Annual Listing Fees. The company is also under the Enhanced Surveillance Measure (ESM) framework since April 15, 2026. A request for revocation of the trading suspension is under process. ## Peer comparison N/A ## Context metrics (time-bound) * **SPA Price:** ₹1.80 per share (20.95% stake) * **Open Offer Price:** ₹4.80 per share (26% stake) * **Total Consideration (full acceptance):** ₹1.88 crore * **Trading Restriction:** Mondays only * **ESM Framework:** Effective April 15, 2026 ## What to track next The market will closely watch the outcome of the open offer and the company's success in getting the trading suspension revoked and exiting the ESM framework. Resolution of pending statutory dues is critical for normal trading to resume. Reader Takeaway: Management control change offers exit opportunity, but regulatory hurdles pose significant risk.
